This study could improve understanding of breast cancer development and lead to identifying new treatment targets.

Florida State University research.

Huntsman Cancer Institute partnered with the Wyoming Survey & Analysis Center for this survey.

FDA approves brain cancer drug, targeting the IDH mutation discovered at the Johns Hopkins Kimmel Cancer Center.

Findings could indicate which patients need immediate treatment and who can be monitored.

The trial was supported by Genentech, Gloria Spivak Faculty Advancement Fund, and Susan G. Komen.

Research team shares new data on how XPO1 blockade may boost immune-based treatments.

The benefit of early surveillance in children prone to cancer.

Researchers say socioeconomic factors may affect a person’s ability to be diagnosed and treated.

Metastatic prostate cancer accounts for 5–10% of all prostate cancer diagnoses, but it is responsible for nearly 50% of prostate cancer-related deaths.